Blood Draw – Mobile Health Times

Babson Diagnostics $31 Million Series B to DriveRetailization of Customer-First, Highly AccessibleDiagnostic Blood Testing

Devices M&A and Finance Pharma & Life Sciences

Babson Diagnostics $31 Million Series B to Drive
Retailization of Customer-First, Highly Accessible
Diagnostic Blood Testing

Drawbridge Health Receives FDA 510(k) Clearance for OneDraw™ A1C Test System

Devices Innovation & Technology

Drawbridge Health Receives FDA 510(k) Clearance for OneDraw™ A1C Test System

Drawbridge Health today announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for the OneDraw™…